The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Differential effects of MDMA and methylphenidate on social cognition
Open accessAbstract
Social cognition is important in everyday-life social interactions. The social cognitive effects of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') and methylphenidate (both used for neuroenhancement and as party drugs) are largely unknown. We investigated the acute effects of MDMA (75 mg), methylphenidate (40 mg) and placebo using the Facial Emotion Recognition Task, Multifaceted Empathy Test, Movie for the Assessment of Social Cognition, Social Value Orientation Test and the Moral Judgment Task in a cross-over study in 30 healthy subjects. Additionally, subjective, autonomic, pharmacokinetic, endocrine and adverse drug effects were measured. MDMA enhanced emotional empathy for positive emotionally charged situations in the MET and tended to reduce the recognition of sad faces in the Facial Emotion Recognition Task. MDMA had no effects on cognitive empathy in the Multifaceted Empathy Test or social cognitive inferences in the Movie for the Assessment of Social Cognition. MDMA produced subjective 'empathogenic' effects, such as drug liking, closeness to others, openness and trust. In contrast, methylphenidate lacked such subjective effects and did not alter emotional processing, empathy or mental perspective-taking. MDMA but not methylphenidate increased the plasma levels of oxytocin and prolactin. None of the drugs influenced moral judgment. Effects on emotion recognition and emotional empathy were evident at a low dose of MDMA and likely contribute to the popularity of the drug.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“By decreasing reactivity to perceived criticism and enhancing emotional empathy (152), MDMA may help narcissistic patients tolerate vulnerability and interpersonal closeness without triggering defensiveness.”
From Psychoanalytically informed MDMA-assisted therapy for pathological narcissism: a novel theoretical approach (2025) · cites this paper as [152]
In the citing paper
“It enhances affective empathy for positive emotions while impairing recognition of negative emotions, such as sadness or fear, which could potentially help narcissistic individuals tolerate and engage with emotions they would otherwise suppress (152).”
From Psychoanalytically informed MDMA-assisted therapy for pathological narcissism: a novel theoretical approach (2025) · cites this paper as [152]
In the citing paper
“In two studies this increase was particularly pronounced in response to positive stimuli and in male participants (10, 51).”
From Modulation of Social Cognition via Hallucinogens and “Entactogens” (2019) · cites this paper as [51]
In the citing paper
“One hundred twenty-five milligrams as well as 75 mg MDMA increased emotional empathy (10, 51, 52).”
From Modulation of Social Cognition via Hallucinogens and “Entactogens” (2019) · cites this paper as [51]
In the citing paper
“In line with this, MDMA (75, 100, & 125 mg), GHB (20 mg/kg), and psilocybin (0.215 mg/kg) did not affect cognitive empathy on the MET (10, 12, 51–53, 62).”
From Modulation of Social Cognition via Hallucinogens and “Entactogens” (2019) · cites this paper as [51]
In the citing paper
“Using moral dilemma tasks, it has been shown that neither MDMA (75 mg) nor psilocybin (0.215 mg/kg) influenced moral decision making (12, 51).”
From Modulation of Social Cognition via Hallucinogens and “Entactogens” (2019) · cites this paper as [51]
In the citing paper
“While MDMA did not change behavior on the SVO when administered in a lower dose (75 mg) (51)”
From Modulation of Social Cognition via Hallucinogens and “Entactogens” (2019) · cites this paper as [51]
In the citing paper
“For example, increases in emotional empathy, impaired identification of negative emotions, enhanced decoding of positive facial expressions, and increased altruistic choices after MDMA administration were not related to oxytocin plasma levels or other neuroendocrine effects (10, 51, 52, 54).”
From Modulation of Social Cognition via Hallucinogens and “Entactogens” (2019) · cites this paper as [51]
In the citing paper
“Interestingly, these social functions were not influenced by acute administration of MDMA in controlled studies (10, 51, 52).”
From Modulation of Social Cognition via Hallucinogens and “Entactogens” (2019) · cites this paper as [51]
In the citing paper
“Decreased recognition of negative emotions induced by psilocybin on the RMET was blocked by pretreatment with the 5-HT2A receptor antagonist ketanserin (51).”
From Modulation of Social Cognition via Hallucinogens and “Entactogens” (2019) · cites this paper as [51]
In the citing paper
“Furthermore, methylphenidate lacked the empathy enhancing properties of MDMA (51).”
From Modulation of Social Cognition via Hallucinogens and “Entactogens” (2019) · cites this paper as [51]
In the citing paper
“LSD and MDMA have shown some dose-dependent effects on empathy and altruistic behavior (10, 33, 51), indicating that robust modulations are measurable at doses of 100 mg MDMA/100µg LSD and above.”
From Modulation of Social Cognition via Hallucinogens and “Entactogens” (2019) · cites this paper as [51]
Citations
Cites
Measuring Social Value OrientationPreprint
Murphy, R. O., Ackermann, K., & Handgraaf, M. (2011) · Social Science Research Network · doi:10.2139/ssrn.1804189 · Cited by 1,099
Dziobek, I., Rogers, K., Fleck, S., Bahnemann, M., Heekeren, H. R., Wolf, O. T., & Convit, A. (2008) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-007-0486-x · Cited by 951
Measuring Social Value Orientation
Murphy, R. O., Ackermann, K. A., & Handgraaf, M. J. J. (2011) · Judgment and Decision Making · doi:10.1017/s1930297500004204 · Cited by 948
Introducing MASC: A Movie for the Assessment of Social Cognition
Dziobek, I., Fleck, S., Kalbe, E., Rogers, K., Hassenstab, J., Brand, M., Kessler, J., Woike, J. K., Wolf, O. T., & Convit, A. (2006) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-006-0107-0 · Cited by 926
McCabe, S. E., Knight, J. R., Teter, C. J., & Wechsler, H. (2004) · Addiction · doi:10.1111/j.1360-0443.2005.00944.x · Cited by 880
Oxytocin enhances amygdala-dependent, socially reinforced learning and emotional empathy in humans
Hurlemann, R., Patin, A., Onur, O. A., Cohen, M. X., Baumgartner, T., Metzler, S., Dziobek, I., Gallinat, J., Wagner, M., Maier, W., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.5538-09.2010 · Cited by 771
Psychometric evaluation of the altered states of consciousness rating scale (OAV)
Studerus, E., Gamma, A., & Vollenweider, F. X. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012412 · Cited by 683
Mithoefer, M. C., Wagner, M. T., Mithoefer, A. T., Jerome, L., & Doblin, R. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881110378371 · Cited by 674
Harmer, C. J., Shelley, N. C., Cowen, P. J., & Goodwin, G. M. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.7.1256 · Cited by 554
Serotonin selectively influences moral judgment and behavior through effects on harm aversion
Crockett, M. J., Clark, L., Hauser, M. D., & Robbins, T. W. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009396107 · Cited by 526
Self-citation
Research works printed but not linked: 3
- Hysek CM, 2013, Soc Cogn Affect Neurosci
- Janke W, 1978, Die Eigenschaftswörterliste
- Zerssen DV, 1976, Die Beschwerden-Liste. Münchener Informationssystem
Cited by
Sorted by citations
Serotonin and brain function: a tale of two receptors
Carhart-Harris, R., & Nutt, D. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117725915 · Cited by 739
Acute Effects of Lysergic Acid Diethylamide in Healthy Subjects
Schmid, Y., Enzler, F., Gasser, P., Grouzmann, E., Preller, K. H., Vollenweider, F. X., Brenneisen, R., Müller, F., Borgwardt, S., & Liechti, M. E. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.11.015 · Cited by 427
Self-citationReviewing the Potential of Psychedelics for the Treatment of PTSD
Krediet, E., Bostoen, T., Breeksema, J., van Schagen, A., Passie, T., & Vermetten, E. (2020) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyaa018 · Cited by 260
LSD Acutely Impairs Fear Recognition and Enhances Emotional Empathy and Sociality
Dolder, P. C., Schmid, Y., Müller, F., Borgwardt, S., & Liechti, M. E. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.82 · Cited by 247
Self-citationDistinct acute effects of LSD, MDMA, and d-amphetamine in healthy subjects
Holze, F., Vizeli, P., Müller, F., Ley, L., Duerig, R., Varghese, N., Eckert, A., Borgwardt, S., & Liechti, M. E. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-019-0569-3 · Cited by 247
Self-citationEffect of Psilocybin on Empathy and Moral Decision-Making
Pokorny, T., Preller, K. H., Kometer, M., Dziobek, I., & Vollenweider, F. X. (2017) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx047 · Cited by 197
Alterations of consciousness and mystical-type experiences after acute LSD in humans
Liechti, M. E., Dolder, P. C., & Schmid, Y. (2017) · Psychopharmacology · doi:10.1007/s00213-016-4453-0 · Cited by 198
Self-citationSub-Acute Effects of Psilocybin on Empathy, Creative Thinking, and Subjective Well-Being
Mason, N. L., Mischler, E., Uthaug, M. V., & Kuypers, K. P. C. (2019) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2019.1580804 · Cited by 172
Kamilar-Britt, P., & Bedi, G. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.08.016 · Cited by 163
Jerome, L., Feduccia, A. A., Wang, J. B., Hamilton, S., Yazar-Klosinski, B., Emerson, A., Mithoefer, M. C., & Doblin, R. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05548-2 · Cited by 159
RetractedSafety pharmacology of acute MDMA administration in healthy subjects
Vizeli, P., & Liechti, M. E. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117691569 · Cited by 157
Self-citationYao, Y., Guo, D., Lu, T., Liu, F.-L., Huang, S., Diao, M.-Q., Li, S., Zhang, X.-J., Kosten, T. R., Shi, J., et al. (2024) · Psychiatry Research · doi:10.1016/j.psychres.2024.115886 · Cited by 162
A meta-analytic review of the correlation between peripheral oxytocin and cortisol concentrations
Brown, C. A., Cardoso, C., & Ellenbogen, M. A. (2016) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2016.11.001 · Cited by 133
Acute Effects of Lysergic Acid Diethylamide on Circulating Steroid Levels in Healthy Subjects
Strajhar, P., Schmid, Y., Liakoni, E., Dolder, P. C., Rentsch, K., Kratschmar, D. V., Odermatt, A., & Liechti, M. E. (2016) · Journal of Neuroendocrinology · doi:10.1111/jne.12374 · Cited by 140
Self-citationDolder, P. C., Müller, F., Schmid, Y., Borgwardt, S. J., & Liechti, M. E. (2018) · Psychopharmacology · doi:10.1007/s00213-017-4650-5 · Cited by 117
Self-citationThe effects of MDMA on socio-emotional processing: Does MDMA differ from other stimulants
Bershad, A. K., Miller, M. A., Baggott, M. J., & de Wit, H. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116663120 · Cited by 106
Dark Classics in Chemical Neuroscience: 3,4-Methylenedioxymethamphetamine
Dunlap, L. E., Andrews, A. M., & Olson, D. E. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00155 · Cited by 106
A Conserved Role for Serotonergic Neurotransmission in Mediating Social Behavior in Octopus
Edsinger, E., & Dölen, G. (2018) · Current Biology · doi:10.1016/j.cub.2018.07.061 · Cited by 104
Kuypers, K. P., Dolder, P. C., Ramaekers, J. G., & Liechti, M. E. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117699617 · Cited by 89
“The psychoactive substance in ecstasy, 3,4-methylenedioxymethamphetamine (MDMA), is known for its empathogenic effects such as increased happiness, openness, trust and closeness to others (Kirkpatrick et al., 2014b; Schmid et al., 2014).”
BackgroundMethodResultInfluentialSelf-citationKiraga, M. K., Mason, N. L., Uthaug, M. V., van Oorsouw, K. I. M., Toennes, S. W., Ramaekers, J. G., & Kuypers, K. P. C. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.721537 · Cited by 85
Psilocybin and MDMA for the treatment of trauma-related psychopathology
Bird, C., Modlin, N. L., & Rucker, J. (2021) · International Review of Psychiatry · doi:10.1080/09540261.2021.1919062 · Cited by 94
The Psychedelic Future of Post-Traumatic Stress Disorder Treatment
Zaretsky, T. G., Jagodnik, K. M., Barsic, R., Antonio, J. H., Bonanno, P. A., MacLeod, C., Pierce, C., Carney, H., Morrison, M. T., Saylor, C. F., et al. (2024) · Current Neuropharmacology · doi:10.2174/1570159x22666231027111147 · Cited by 92
Acute subjective effects in LSD- and MDMA-assisted psychotherapy
Schmid, Y., Gasser, P., Oehen, P., & Liechti, M. E. (2021) · Journal of Psychopharmacology · doi:10.1177/0269881120959604 · Cited by 85
Self-citationProgress and promise for the MDMA drug development program
Feduccia, A. A., Holland, J. A., & Mithoefer, M. C. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4779-2 · Cited by 82
Modulation of Social Cognition via Hallucinogens and “Entactogens”
Preller, K. H., & Vollenweider, F. X. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00881 · Cited by 71
Effects of MDMA on attention to positive social cues and pleasantness of affective touch
Bershad, A. K., Mayo, L. M., Hedger, K. V., McGlone, F. P., Walker, S. C., & de Wit, H. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0402-z · Cited by 76
Therapeutic mechanisms of psychedelics and entactogens
Heifets, B. D., & Olson, D. E. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-023-01666-5 · Cited by 70
Luethi, D., & Liechti, M. E. (2018) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyy047 · Cited by 70
Self-citationNeuroimaging in moderate MDMA use: A systematic review
Müller, F., Lenz, C., Steiner, M. D., Dolder, P. C., Walter, M., Lang, U. E., Liechti, M. E., & Borgwardt, S. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.12.010 · Cited by 71
Self-citationRepantis, D., Bovy, L., Ohla, K., Kühn, S., & Dresler, M. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05691-w · Cited by 75
Role of the 5-HT2A Receptor in Acute Effects of LSD on Empathy and Circulating Oxytocin
Holze, F., Avedisian, I., Varghese, N., Eckert, A., & Liechti, M. E. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.711255 · Cited by 73
Self-citationOxytocin: Parallel Processing in the Social Brain?
Dölen, G. (2015) · Journal of Neuroendocrinology · doi:10.1111/jne.12284 · Cited by 65
Effects of MDMA on body temperature in humans
Liechti, M. E. (2014) · Temperature · doi:10.4161/23328940.2014.955433 · Cited by 69
Self-citationAtila, C., Holze, F., Murugesu, R., Rommers, N., Hutter, N., Varghese, N., Sailer, C. O., Eckert, A., Heinrichs, M., Liechti, M. E., et al. (2023) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(23)00120-1 · Cited by 68
Self-citationRoberts, C., Sahakian, B. J., & Robbins, T. W. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.09.001 · Cited by 63
MDMA and MDMA-assisted therapy
Wolfgang, A. S., Fonzo, G. A., Gray, J. C., Krystal, J. H., Grzenda, A., Widge, A. S., Kraguljac, N. V., McDonald, W. M., Rodriguez, C. I., & Nemeroff, C. B. (2025) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20230681 · Cited by 62
Maurage, P., D’Hondt, F., de Timary, P., Mary, C., Franck, N., & Peyroux, É. (2016) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13155 · Cited by 69
Dolder, P. C., Strajhar, P., Vizeli, P., Hammann, F., Odermatt, A., & Liechti, M. E. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00617 · Cited by 61
Self-citationMaples‐Keller, J. L., Norrholm, S. D., Burton, M. S., Reiff, C. M., Coghlan, C., Jovanović, T., Yasinski, C. W., Jarboe, K. S., Rakofsky, J. J., Rauch, S. A. M., et al. (2022) · Journal of Psychopharmacology · doi:10.1177/02698811211069124 · Cited by 58
Pharmacology of MDMA- and Amphetamine-Like New Psychoactive Substances
Simmler, L. D., & Liechti, M. E. (2018) · Handbook of experimental pharmacology · doi:10.1007/164_2018_113 · Cited by 58
Self-citationIsness: Using Multi-Person VR to Design Peak Mystical Type Experiences Comparable to Psychedelics
Glowacki, D. R., Wonnacott, M. D., Freire, R., Glowacki, B. R., Gale, E. M., Pike, J. E., de Haan, T., Chatziapostolou, M., & Metatla, O. (2020) · Proceedings of the 2020 CHI Conference on Human Factors in Computing Systems · doi:10.1145/3313831.3376649 · Cited by 54
Prediction of MDMA response in healthy humans: a pooled analysis of placebo-controlled studies
Studerus, E., Vizeli, P., Harder, S., Ley, L., & Liechti, M. E. (2021) · Journal of Psychopharmacology · doi:10.1177/0269881121998322 · Cited by 57
Self-citationDürsteler, K. M., Berger, E.-M., Strasser, H., Caflisch, C., Mutschler, J., Herdener, M., & Vogel, M. (2015) · Substance Abuse and Rehabilitation · doi:10.2147/sar.s50807 · Cited by 50
Interactions between Bupropion and 3,4-Methylenedioxymethamphetamine in Healthy Subjects
Schmid, Y., Rickli, A., Schaffner, A., Duthaler, U., Grouzmann, E., Hysek, C. M., & Liechti, M. E. (2015) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.222356 · Cited by 51
Self-citationDolder, P. C., Holze, F., Liakoni, E., Harder, S., Schmid, Y., & Liechti, M. E. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4431-6 · Cited by 52
Self-citationGroup VR experiences can produce ego attenuation and connectedness comparable to psychedelics
Glowacki, D. R., Williams, R. R., Wonnacott, M., Maynard, O., Freire, R., Pike, J. E., & Chatziapostolou, M. (2022) · Scientific Reports · doi:10.1038/s41598-022-12637-z · Cited by 64
Vizeli, P., Schmid, Y., Prestin, K., zu Schwabedissen, H. E. M., & Liechti, M. E. (2017) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2017.01.008 · Cited by 50
Self-citationVizeli, P., Straumann, I., Duthaler, U., Varghese, N., Eckert, A., Paulus, M. P., Risbrough, V. B., & Liechti, M. E. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.906639 · Cited by 47
Self-citationUrinary and plasma oxytocin changes in response to MDMA or intranasal oxytocin administration
Francis, S. M., Kirkpatrick, M. G., de Wit, H., & Jacob, S. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.08.011 · Cited by 46
Maier, L. J., Wunderli, M. D., Vonmoos, M., Roemmelt, A. T., Baumgartner, M. R., Seifritz, E., Schaub, M. P., & Quednow, B. B. (2015) · PLoS ONE · doi:10.1371/journal.pone.0129805 · Cited by 46
Self-citationMDMA: a social drug in a social context
Kirkpatrick, M. G., & de Wit, H. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3752-6 · Cited by 48
Music-induced positive mood broadens the scope of auditory attention
Putkinen, V., Makkonen, T., & Eerola, T. (2017) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nsx038 · Cited by 48
Rocha, J. M., Osório, F. D. L., Crippa, J. A. S., Bouso, J. C., Rossi, G. N., Hallak, J. E. C., & SANTOS, R. G. D. (2019) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125319845774 · Cited by 43
Bosch, O. G., Eisenegger, C., Gertsch, J., von Rotz, R., Dornbierer, D., Gachet, M. S., Heinrichs, M., Wetter, T. C., Seifritz, E., & Quednow, B. B. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.07.167 · Cited by 42
Self-citationGabay, A. S., Kempton, M. J., Gilleen, J., & Mehta, M. A. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.1276-18.2018 · Cited by 40
Effects of methylphenidate and MDMA on appraisal of erotic stimuli and intimate relationships
Schmid, Y., Hysek, C. M., Preller, K. H., Bosch, O. G., Bilderbeck, A. C., Rogers, R. D., Quednow, B. B., & Liechti, M. E. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.11.020 · Cited by 40
Self-citationSchmidt, A., Müller, F., Dolder, P. C., Schmid, Y., Zanchi, D., Liechti, M. E., & Borgwardt, S. (2017) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx037 · Cited by 41
Self-citationConsidering the context: social factors in responses to drugs in humans
de Wit, H., & Sayette, M. A. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4854-3 · Cited by 42
Borissova, A., Ferguson, B., Wall, M. B., Morgan, C. J. A., Carhart-Harris, R. L., Bolstridge, M., Bloomfield, M., Williams, T. M., Feilding, A., Murphy, K., et al. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881120926673 · Cited by 39
Müller, F., Holze, F., Dolder, P. C., Ley, L., Vizeli, P., Soltermann, A., Liechti, M. E., & Borgwardt, S. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-00906-2 · Cited by 39
Self-citationZeifman, R. J., Kettner, H., Ross, S., Weiss, B., Mithoefer, M. C., Mithoefer, A. T., & Wagner, A. C. (2024) · European Journal of Psychotraumatology · doi:10.1080/20008066.2023.2297536 · Cited by 37
MDMA enhances empathy-like behaviors in mice via 5-HT release in the nucleus accumbens
Rein, B. A., Raymond, K. B., Boustani, C., Tuy, S., Zhang, J., Laurent, R. S., Pomrenze, M. B., Boroon, P., Heifets, B. D., Smith, M. L., et al. (2024) · Science Advances · doi:10.1126/sciadv.adl6554 · Cited by 40
Psilocybin and MDMA reduce costly punishment in the Ultimatum Game
Gabay, A. S., Carhart-Harris, R. L., Mazibuko, N., Kempton, M. J., Morrison, P. D., Nutt, D., & Mehta, M. A. (2018) · Scientific Reports · doi:10.1038/s41598-018-26656-2 · Cited by 41
Vizeli, P., & Liechti, M. E. (2018) · PLoS ONE · doi:10.1371/journal.pone.0199384 · Cited by 37
Self-citationDolder, P. C., Strajhar, P., Vizeli, P., Odermatt, A., & Liechti, M. E. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4849-0 · Cited by 34
Self-citationMDMA and memory, addiction, and depression: dose-effect analysis
Pantoni, M. M., Kim, J. L., Alstyne, K. R. V., & Anagnostaras, S. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06086-9 · Cited by 41
The Altered States Database: Psychometric data from a systematic literature review
Prugger, J., Derdiyok, E., Dinkelacker, J., Costines, C., & Schmidt, T. T. (2022) · Scientific Data · doi:10.1038/s41597-022-01822-4 · Cited by 36
Drug effects on responses to emotional facial expressions
Miller, M. A., Bershad, A. K., & de Wit, H. (2015) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000164 · Cited by 31
Molla, H. M., Lee, R., Lyubomirsky, S., & de Wit, H. (2023) · Scientific Reports · doi:10.1038/s41598-023-43156-0 · Cited by 32
Avram, M., Fortea, L., Wollner, L., Coenen, R., Korda, A. I., Rogg, H. V., Holze, F., Vizeli, P., Ley, L., Raduà, J., et al. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02734-y · Cited by 32
Self-citationInteractions of Cathinone NPS with Human Transporters and Receptors in Transfected Cells
Simmler, L. D., & Liechti, M. E. (2016) · Current topics in behavioral neurosciences · doi:10.1007/7854_2016_20 · Cited by 29
Self-citationLyubomirsky, S. (2022) · Perspectives on Psychological Science · doi:10.1177/17456916211055369 · Cited by 34
Quednow, B. B. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815298-0.00005-8 · Cited by 31
Self-citationCan psychedelics enhance group psychotherapy? A discussion on the therapeutic factors
Ponomarenko, P., Seragnoli, F., Calder, A. E., Oehen, P., & Hasler, G. (2023) · Journal of Psychopharmacology · doi:10.1177/02698811231155117 · Cited by 31
Acute Effects of Methylphenidate, Modafinil, and MDMA on Negative Emotion Processing
Schmidt, A., Müller, F., Dolder, P. C., Schmid, Y., Zanchi, D., Egloff, L., Liechti, M. E., & Borgwardt, S. (2017) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx112 · Cited by 24
Self-citationEffects of Acute Doses of Prosocial Drugs Methamphetamine and Alcohol on Plasma Oxytocin Levels
Bershad, A. K., Kirkpatrick, M. G., Seiden, J. A., & de Wit, H. (2015) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000314 · Cited by 25
MDMA-induced indifference to negative sounds is mediated by the 5-HT2A receptor
Kuypers, K. P. C., de la Torre, R., Farré, M., Pizarro, N., Xicota, L., & Ramaekers, J. G. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4699-1 · Cited by 26
Wunderli, M. D., Vonmoos, M., Treichler, L., Zeller, C., Dziobek, I., Kræmer, T., Baumgartner, M. R., Seifritz, E., & Quednow, B. B. (2017) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx098 · Cited by 28
Self-citationCarlyle, M., Stevens, T., Fawaz, L., Marsh, B., Kosmider, S., & Morgan, C. J. A. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119826594 · Cited by 25
Increased Internet use and poorer ability to manage emotions in youth at high-risk for psychosis
Pelletier‐Baldelli, A., Ives, L. T., & Mittal, V. A. (2015) · Schizophrenia Research Cognition · doi:10.1016/j.scog.2015.08.002 · Cited by 23
Key interindividual determinants in MDMA pharmacodynamics
Papaseit, E., Torrens, M., Pérez‐Mañá, C., Muga, R., & Farré, M. (2018) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2018.1424832 · Cited by 20
Stocker, K., & Liechti, M. E. (2024) · Journal of Psychopharmacology · doi:10.1177/02698811241265352 · Cited by 19
Self-citationSarmanlu, M., Kuypers, K. P. C., Vizeli, P., & Kvamme, T. L. (2023) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2023.110843 · Cited by 21
Parrott, A. C. (2016) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000262 · Cited by 21
Regan, A., Margolis, S., de Wit, H., & Lyubomirsky, S. (2021) · PLoS ONE · doi:10.1371/journal.pone.0258849 · Cited by 21
Empathic accuracy and oxytocin after tryptophan depletion in adults at risk for depression
Hogenelst, K., Schoevers, R. A., Kema, I. P., Sweep, F. C. G. J., & Rot, M. A. H. (2015) · Psychopharmacology · doi:10.1007/s00213-015-4093-9 · Cited by 16
Boxler, M. I., Liechti, M. E., Schmid, Y., Kræmer, T., & Steuer, A. E. (2017) · Journal of Proteome Research · doi:10.1021/acs.jproteome.7b00294 · Cited by 17
Self-citationAguilar, M. A., García-Pardo, M. P., & Parrott, A. C. (2019) · Brain Research · doi:10.1016/j.brainres.2019.146556 · Cited by 18
Strajhar, P., Vizeli, P., Patt, M., Dolder, P. C., Kratschmar, D. V., Liechti, M. E., & Odermatt, A. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2018.10.016 · Cited by 17
Self-citationMDMA for the treatment of mood disorder: all talk no substance?
Patel, R., & Titheradge, D. (2015) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125315583786 · Cited by 17
Howlett, J. R., Huang, H., Hysek, C. M., & Paulus, M. P. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4723-5 · Cited by 14
Self-citationPouyan, N., Sisi, F. Y., Kargar, A., Scheidegger, M., McIntyre, R. S., & Morrow, J. D. (2023) · CNS Drugs · doi:10.1007/s40263-023-01044-1 · Cited by 13
Vizeli, P., zu Schwabedissen, H. E. M., & Liechti, M. E. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00590 · Cited by 13
Self-citationMohamed, A., Touheed, S., Ahmed, M., Hor, M., & Fatima, S. (2022) · Cureus · doi:10.7759/cureus.30919 · Cited by 17
A Review of MDMA-Assisted Therapy for Posttraumatic Stress Disorder
Lewis, B. R., & Byrne, K. (2023) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.20220088 · Cited by 14
Schmid, Y., & Bershad, A. K. (2024) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2024.02.001 · Cited by 15
Self-citationZacher, A., Zimmermann, J., Cole, D. M., Friedli, N., Opitz, A., Baumgartner, M. R., Steuer, A., Verdejo-García, A., Stock, A., Beste, C., et al. (2024) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2024.04.010 · Cited by 11
Self-citationSocial Psychopharmacology: Novel Approaches to Treat Deficits in Social Motivation in Schizophrenia
Bershad, A. K., & de Wit, H. (2023) · Schizophrenia Bulletin · doi:10.1093/schbul/sbad094 · Cited by 12
MDMA does not alter responses to the Trier Social Stress Test in humans
Bershad, A. K., Miller, M. A., & de Wit, H. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4621-x · Cited by 13
LSD acutely impairs fear recognition and enhances emotional empathy and sociality
Dolder, P. C. (2016) · doi:10.26226/morressier.5785edc6d462b80296c9935b · Cited by 13
Metadata
- Authors
- Schmid, Y., Hysek, C. M., Simmler, L. D., Crockett, M. J., Quednow, B. B., & Liechti, M. E.
- Affiliations
- University Hospital of Basel (CH)
- Wellcome Centre for Human Neuroimaging (GB)
- University Hospital Zurich (CH)
- Corresponding author
- Liechti, Matthias E
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2014-07-22
- Volume
- 28
- Issue
- 9
- Pages
- 847-856
- ISSN
- 0269-8811 (ISSN-L)
- 1461-7285
- OpenAlex
- W2073612520
- Cited by
- 155
- References
- 37
- Citations by year
- 2026: 12 · 2025: 10 · 2024: 16 · 2023: 14 · 2022: 7 · 2021: 12 · 2020: 10 · 2019: 10 · 2018: 18 · 2017: 16 · 2016: 14 · 2015: 12 · 2014: 4
- FWCI
- 18.09
- Type
- journal article
- Language
- en
- Open access
- green
- edoc.unibas.ch
- Locations
- Journal of Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- edoc (University of Basel) (acceptedVersion, other-oa)
- UCL Discovery (University College London) (submittedVersion)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
- edoc (University of Basel)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Social Sciences › Arts and Humanities › Philosophy › Neuroethics, Human Enhancement, Biomedical Innovations
- Keywords
- MDMA, ecstasy, methylphenidate, social cognition, affective empathy, cognitive empathy, facial emotion recognition, social value orientation, moral judgment, oxytocin, prolactin, subjective effects, acute drug effects, cognitive enhancement
- MeSH terms
- Adolescent, Adult, Central Nervous System Stimulants, Cognition, Dose-Response Relationship, Drug, Double-Blind Method, Emotions, Empathy, Epinephrine, Facial Expression, Female, Hallucinogens, Humans, Hydrocortisone, Judgment, Male, Methylphenidate, Oxytocin, Prolactin, Cross-Over Studies, N-Methyl-3,4-methylenedioxyamphetamine, Recognition, Psychology, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
